{"id":744812,"date":"2023-04-03T16:03:19","date_gmt":"2023-04-03T20:03:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/"},"modified":"2023-04-03T16:03:19","modified_gmt":"2023-04-03T20:03:19","slug":"regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/","title":{"rendered":"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"start\">TARRYTOWN, N.Y., April  03, 2023  (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:<strong> REGN<\/strong>) today announced that it will report its first quarter 2023 financial and operating results on Thursday, May 4, 2023, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.<\/p>\n<p align=\"start\">\n        <strong>Conference Call Information<\/strong><br \/>\n        <br \/> Participants may access the conference call live via webcast on the \u2018Investors and Media\u2019 page of Regeneron\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GYcjJsDnPg2vk-V_f2Th98fZEyLhk6wJKWmY3NYUNkQFQXVOFsKXEUxIi31efMLe5ZUkyq66AMlxDHCcF8aSfl0k7E3f89WpszJEV93TBJt69zwRhjK2e9fTLfpG46Is\" rel=\"nofollow noopener\" target=\"_blank\"><u>https:\/\/investor.regeneron.com<\/u><\/a>. To participate via telephone, please register in advance at this\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Kx5kqdUlTAeJvMY7BoPnJzrhxrR9B_PFCEaCZFl9OJcYuDO623nzUASKS_AFHNdby8GifRiUJadD5xt9BhO6wfWX5pWrq9Jp2kxIX4hRd6pg_YgBSvuJApJITp5WFWNYN73L3lfVJJEYZMHjvD5bzG2jyuKJBCVN1rrH5qcLtUDAAaNwgsgY1QhmMk-9TMaOVWveZrPYR7_LM8pZ8Yc_iWWL1Ya7BwaLOV-OIwaZt0Ze9MoxYU-NvhIuVZPt-yTSpu_AZDq3Z6yq32y-8LiukjmNgEmJOB9BlvhHUzeFUJHAKVCx_v0DZ0uAld6ZU4pw\" rel=\"nofollow noopener\" target=\"_blank\"><u>link<\/u><\/a>.\u00a0Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the conference call and webcast will be archived on the Company\u2019s website for at least 30 days.<\/p>\n<p align=\"start\">\n        <strong>About<\/strong>\u00a0<strong>Regeneron<\/strong><br \/> Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases.<\/p>\n<p align=\"start\">Regeneron is accelerating and improving the traditional drug development process through our proprietary <em>VelociSuite\u00ae <\/em>technologies, such as <em>VelocImmune\u00ae<\/em>, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.<\/p>\n<p align=\"start\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SngRLeRoVPQiY9DpVXRnyloaZj33Xn3kk2BMwP2QmrivuQSFILwo1TQLteiiWqeEYRI8dN-ipM5h7i15bRH3Qw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.Regeneron.com<\/u><\/a> or follow @Regeneron on Twitter.<\/p>\n<p align=\"start\">\n        <strong>Contact Information:<\/strong><br \/>\n        <br \/> Investor Relations <br \/> Ryan Crowe <br \/> 914.847.8790 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pQdQcL-PBGvYN8fmOsVd-lBX6Cd9H_KlmfMKoe9gPie6oDa0XBnz9E7SPA5fgxt7lYmfvOco3GCB4mrha6BxoKHo0_8AesveLjaYojw96DU=\" rel=\"nofollow noopener\" target=\"_blank\"><u>ryan.crowe@regeneron.com<\/u><\/a><\/p>\n<p align=\"start\">Corporate Communications <br \/> Christina Chan <br \/> 914.847.8827 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_ud9gYvlN2e4v56EyY_qcJwnYJhJYQ-KmrBIraiALoVc5_eb4CLTGrviI6CW3ORbKNy7Q4k8d9wG8Sj3YLu-RjYTJ4E3-aEecy3uoEARCYoUgShXn31PrRnIie44xi4p\" rel=\"nofollow noopener\" target=\"_blank\"><u>christina.chan@regeneron.com<\/u><\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NDk2ZWJhOGEtZGY5Zi00N2Y0LWE3M2UtNTE3ZWY4ZDgwNzdhLTEwMTc4MjM=\/tiny\/Regeneron-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TARRYTOWN, N.Y., April 03, 2023 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2023 financial and operating results on Thursday, May 4, 2023, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information Participants may access the conference call live via webcast on the \u2018Investors and Media\u2019 page of Regeneron\u2019s website at\u00a0https:\/\/investor.regeneron.com. To participate via telephone, please register in advance at this\u00a0link.\u00a0Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-744812","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TARRYTOWN, N.Y., April 03, 2023 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2023 financial and operating results on Thursday, May 4, 2023, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information Participants may access the conference call live via webcast on the \u2018Investors and Media\u2019 page of Regeneron\u2019s website at\u00a0https:\/\/investor.regeneron.com. To participate via telephone, please register in advance at this\u00a0link.\u00a0Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to &hellip; Continue reading &quot;Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-03T20:03:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023\",\"datePublished\":\"2023-04-03T20:03:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/\"},\"wordCount\":341,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/\",\"name\":\"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=\",\"datePublished\":\"2023-04-03T20:03:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/","og_locale":"en_US","og_type":"article","og_title":"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023 - Market Newsdesk","og_description":"TARRYTOWN, N.Y., April 03, 2023 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2023 financial and operating results on Thursday, May 4, 2023, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information Participants may access the conference call live via webcast on the \u2018Investors and Media\u2019 page of Regeneron\u2019s website at\u00a0https:\/\/investor.regeneron.com. To participate via telephone, please register in advance at this\u00a0link.\u00a0Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to &hellip; Continue reading \"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-03T20:03:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023","datePublished":"2023-04-03T20:03:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/"},"wordCount":341,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/","name":"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=","datePublished":"2023-04-03T20:03:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NzA1NiM1NDk2MTIzIzIwMDYyNTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2023-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/744812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=744812"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/744812\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=744812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=744812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=744812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}